The table below provides a list of the drugs associated with non-serious adverse events identified in the scientific literature over the last week.
| Non-serious case reports | ||
| Drug name(s) | Adverse event(s) | No. of cases |
| Acetazolamide | Fatigue | 1 |
| Adalimumab | Pustular psoriasis | 1 |
| Aluminium, Hib DTaP poliovirus vaccine | Granuloma, Injection site reactions | 1 |
| Aminolevulinic acid | Folliculitis, Pain, Signs and symptoms | 1 |
| Amlodipine, Aripiprazole, Bupropion, Escitalopram, Gabapentin, Memantine, Metoprolol succinate, Pramipexole | Abnormal laboratory parameters, Fatigue, Lightheadedness, Sedation | 1 |
| Amlodipine/valsartan/hydrochlorothiazide | Hypertension, Vertigo | 1 |
| Apremilast, Ciclosporin, Prednisone | Nausea | 1 |
| Avapritinib | Angioedema, Eye Disorders, Oedema, Periorbital oedema, Skin disorders | 1 |
| AZD 1222 | Asthenia, Cough, Diaphoresis, Diarrhoea, Fever, Injection site pain, Lightheadedness, Pharyngitis | 1 |
| Azithromycin | Gastrointestinal disorders, Nausea | 1 |
| Benzyl alcohol, Hydrocortisone | Contact dermatitis | 1 |
| Bevacizumab, Dacomitinib | Epistaxis, Exanthema, Skin disorders | 2 |
| Carbamazepine | Dizziness | 1 |
| Carboplatin, Paclitaxel, Sintilimab | Diarrhoea, Nausea | 1 |
| Cisplatin, Gemcitabine, Gimeracil/oteracil/tegafur | Anorexia, Malaise | 1 |
| Cotrimoxazole | Delayed hypersensitivity | 1 |
| COVID 19 vaccine Gamaleya National Research Center of Epidemiology and Microbiology | Herpes zoster, Skin disorders | 1 |
| Dapsone, Tacrolimus | Gastrointestinal disorders | 1 |
| Dasatinib, Imatinib | Asthenia, Fatigue | 1 |
| Doxorubicin liposomal | Alopecia, Liver disorders, Nausea | 3 |
| Dupilumab | Keratoconjunctivitis | 1 |
| Dupilumab | Urticaria | 1 |
| Eculizumab | Hypersensitivity | 1 |
| Elasomeran, Tozinameran | Orbit disorders | 3 |
| Elasomeran, Tozinameran | Penile diseases, Phlebitis | 5 |
| Erenumab | Fatigue, Gastrointestinal disorders, Migraine, Nausea | 2 |
| Ethosuximide | Gastrointestinal disorders | 1 |
| Favipiravir | Eye Disorders, Nail disorders, Tooth disorders | 3 |
| Fluoxetine | QT interval prolongation | 1 |
| Hexachlorophene, Povidone iodine | Skin disorders | 2 |
| Hydrocortisone, Mitotane | Abnormal laboratory parameters, Nausea, Vomiting | 1 |
| Immune globulin | False test results, Pregnancy | 1 |
| Infliximab | Infusion related reaction | 1 |
| INM 005 | Pruritus, Urticaria | 2 |
| Isoniazid | Exanthema | 1 |
| Lenvatinib | Depression, Erythrodysaesthesia | 1 |
| Leuprorelin, Triptorelin | Hypersensitivity, Musculoskeletal disorders, Tremor | 7 |
| Levodopa | Hypersensitivity | 1 |
| Liraglutide | Nausea | 1 |
| Lisinopril, Metoprolol succinate | Hypotension, Lightheadedness | 1 |
| Methotrexate | Pigmentation | 1 |
| Minoxidil | Allergic contact dermatitis, Hypertrichosis | 9 |
| Mirabegron | Abdominal pain, Chest pain, Dizziness, Headache, Hypertension, Malaise, Nausea, Vision disorders | 7 |
| MMR varicella zoster virus vaccine | Herpes zoster | 1 |
| Nadolol | Signs symptoms and ill defined conditions | 1 |
| Nivolumab | Circumscribed scleroderma | 1 |
| Pemigatinib | Nail disorders | 1 |
| Pertuzumab/trastuzumab | Injection site pain | 1 |
| Phenoxymethylpenicillin | Nausea, Pregnancy, Pruritus | 1 |
| Ponatinib | Hypertension | 1 |
| Prednisolone, Triamcinolone | Acne | 1 |
| Rituximab | Vaccine failure | 1 |
| Rivoceranib | Haemoptysis | 1 |
| Salbutamol | Tremor | 1 |
| SARS COV 2 vaccine inactivated Sinovac Biotech | Vitiligo | 1 |
| Sorafenib | Metaplasia, Skin disorders | 1 |
| Terbinafine | Teratospermia | 1 |
| Tigecycline | Abdominal pain | 1 |
| Tozinameran | Alopecia areata | 1 |
| Tozinameran | Drug hypersensitivity | 11 |
| Tozinameran | Herpes zoster | 1 |
| Tozinameran | Tachycardia | 3 |
| Vedolizumab | Injection site reactions | 1 |
| Vinorelbine | Headache, Muscle pain, Nausea | 3 |
Reference
- Non-serious case reports. Reactions Weekly 8 Jun 2022